These results suggest that TRPA1 is the predominant itch receptor mediating the acute scratching response induced by subcutaneous applications of SADBE, although both TRPA1 and TRPV1 are involved in generating persistent itch in the SADBE-induced ACD model. Here, TRPA1 is linked to granular corneal dystrophy type II.